Reported 11 months ago
This article discusses the manufacturing process of delta-8, a popular hemp-derived product, where CBD isolate is transformed into delta-8 through isomerization. It highlights the lack of official oversight on lab testing which raises concerns about product safety. Readers are advised on how to report adverse reactions to the FDA and the differences between delta-8 and other cannabinoids like THC-P and HHC, emphasizing the levels of psychoactivity and synthetic production. The story is part of a series called Highly Legal by Milwaukee Journal Sentinel in collaboration with The Examination, AL.com, PennLive, and USA TODAY.
Source: YAHOO